Insights into the pharmacological relevance of lysophospholipid receptors.
about
Molecular mechanisms of large-conductance ca (2+) -activated potassium channel activation by ginseng gintoninLysophospholipids and their receptors in the central nervous systemFingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapyLipid phosphate phosphatases and their roles in mammalian physiology and pathologyA novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tensionThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsDistinct phospholipase C-β isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure.Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity.Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue InflammationIdentification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.Altered lysophosphatidic acid (LPA) receptor expression during hepatic regeneration in a mouse model of partial hepatectomySphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes.LPA receptor signaling: pharmacology, physiology, and pathophysiology.Lysophospholipid receptor nomenclature review: IUPHAR Review 8.Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts.Role of LPA and the Hippo pathway on apoptosis in salivary gland epithelial cellsKrüppel-like factor 5 incorporates into the β-catenin/TCF complex in response to LPA in colon cancer cells.Hydrophilic interaction chromatography based solid-phase extraction and MALDI TOF mass spectrometry for revealing the influence of Pseudomonas fluorescens on phospholipids in salmon fillet.A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells.G Protein-Coupled Receptor and RhoA-Stimulated Transcriptional Responses: Links to Inflammation, Differentiation, and Cell Proliferation.The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.Myocardin-Related Transcription Factor A and Yes-Associated Protein Exert Dual Control in G Protein-Coupled Receptor- and RhoA-Mediated Transcriptional Regulation and Cell Proliferation.Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapyA mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases.Sphingosine 1-phosphate receptors are essential mediators of eyelid closure during embryonic developmentLysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase.Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery.Matricellular protein Cyr61 bridges lysophosphatidic acid and integrin pathways leading to cell migration.Lysophosphatidic acid (LPA) and its receptor, LPA1 , influence embryonic schwann cell migration, myelination, and cell-to-axon segregation.Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.Lysophosphatidic Acid Pretreatment Attenuates Myocardial Ischemia/Reperfusion Injury in the Immature Hearts of Rats.Lysophospholipid receptor activation of RhoA and lipid signaling pathways.Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.Industrial natural product chemistry for drug discovery and development.Design of anticancer lysophosphatidic acid agonists and antagonists.Role of sphingomyelinases in neurological disorders.Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation.CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation.An in vivo screening system to identify tumorigenic genes.
P2860
Q21285088-EB648D12-8795-43BD-866B-CB951F7E5CD6Q26859168-EEECECEA-00F2-4148-BD18-7991479DC222Q27011473-7BF3CDD5-F422-4F39-A310-DF6B8463C405Q28088430-0FD4F555-109C-4BD8-84C0-639D9FF54712Q28538027-818CC1BA-EBDC-40EF-A82F-0305AD0A775FQ30486707-57A498B3-B87A-4F37-B91B-BC693F19EB48Q30539636-DBE9D9EE-F071-4091-9B47-67BD1D34C058Q30573574-50A9543E-12CB-458C-A85F-3E1333383246Q30657993-97848518-3ED2-4386-9303-E9A10B726D67Q33610285-6FF8CB21-37D9-4D24-8752-EB2C7913D4FDQ33720930-BDA77219-44FA-441A-A694-834CDD61336FQ33756197-779B7FD3-394B-46C3-9B18-3C0786A36F30Q33825153-4A9028DF-79A0-4A56-8194-5D28F71DCA05Q34025135-E061C864-32D2-4D97-9890-FB95D0CA98FFQ34383078-8E6A3FCA-0CA2-4E33-B9C6-5C6E0FAC8F2AQ34760307-C4A96A09-708E-4B80-A140-8007F9AD4189Q35181424-D7D9406C-A411-4905-ADC6-7DF9B5C15DA6Q35506079-BBC3B681-4DE0-427F-8D8D-BC27091D08BCQ35668656-3F5D92D9-27ED-4ACE-849E-5B166437E9FFQ35745964-8FC5C15F-586F-463A-B7A6-89C24B532591Q36361669-53A26B89-8FD4-439A-819D-4A390C00613EQ36434018-CB800784-6FDF-4AC0-B3CB-605FC608684BQ36799651-EE2E5989-1C3E-44ED-BF68-EB5011A490D6Q36960355-C86E5B49-11D2-421C-B99B-3D9371B0A149Q37163154-8BD67950-945E-4CE2-9D2A-A38AAA8B0606Q37226246-2796CB43-EFDC-4779-BD22-7657890A240AQ37503698-13C3BB9C-E485-46E3-AB12-92BCDB9F6152Q37551932-3DC8F3FD-A556-4E4B-BC36-F94CC048E422Q37608477-8AA6AD9C-D27D-4B9A-8493-35CB992D4B8BQ37615908-CCA3BB45-46BB-4C4B-AB5C-3077BE51448DQ37620329-60E59852-B741-4F0F-8CE1-1457EC5E85AAQ37712457-AEF320E0-B1D9-4FA3-A494-6657AF41BD27Q38044174-2642F79E-A2FC-467A-A9DA-BFD04FE917DAQ38101074-425669EE-B90E-4114-A6D5-4BAC8DA066F3Q38154186-FBF8FAFF-CFCE-4781-A639-78375B7E2878Q38223013-219DE800-8559-4F9B-9512-7111B8B79DDEQ38560939-B8D2B485-7B8C-47D4-8110-477134ED77A0Q38645945-B12EAD48-41F1-4FC5-A3CA-A0D914153559Q38680111-C4C40C6E-CB41-4CEB-AA58-61E207CDA726Q38742816-9CC6E75B-B441-4240-BA49-5732DFACDF49
P2860
Insights into the pharmacological relevance of lysophospholipid receptors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Insights into the pharmacological relevance of lysophospholipid receptors.
@ast
Insights into the pharmacological relevance of lysophospholipid receptors.
@en
type
label
Insights into the pharmacological relevance of lysophospholipid receptors.
@ast
Insights into the pharmacological relevance of lysophospholipid receptors.
@en
prefLabel
Insights into the pharmacological relevance of lysophospholipid receptors.
@ast
Insights into the pharmacological relevance of lysophospholipid receptors.
@en
P2093
P2860
P1476
Insights into the pharmacological relevance of lysophospholipid receptors.
@en
P2093
Jerold Chun
Richard Rivera
Tetsuji Mutoh
P2860
P304
P356
10.1111/J.1476-5381.2011.01622.X
P407
P577
2012-02-01T00:00:00Z